These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Incidence of hypofibrinogenemia under valproate. Could it allow the detection of hepatotoxicity of this drug?]. Coquerel A; Senant J; Samson M; Sauger F; Samson-Dollfus D; Parain D; Leroy A; Hue G; Borg JY; Matray F Presse Med; 1986 Oct; 15(34):1733. PubMed ID: 2947142 [No Abstract] [Full Text] [Related]
13. Epilepsy and IgA deficiency--the effect of sodium valproate. Joubert PH; Aucamp AK; Potgieter GM; Verster F S Afr Med J; 1977 Oct; 52(16):642-4. PubMed ID: 337537 [TBL] [Abstract][Full Text] [Related]
15. [Platelet dysfunction in children during treatment with sodium valproate]. Ikeda N; Mitsudome A; Ogata H; Ohfu M No To Hattatsu; 1984 Jan; 16(1):27-31. PubMed ID: 6424693 [No Abstract] [Full Text] [Related]
16. [Hypofibrinogenemia and intracranial hemorrhage induced by valproic acid: a case report]. Chen HF; Li ZY; Tang JQ Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):682. PubMed ID: 23134874 [No Abstract] [Full Text] [Related]
17. [Thrombocyte values in adults during the treatment with DPA (Ergenyl)]. Krause KH Med Welt; 1977 Jun; 28(24):1098-9. PubMed ID: 331015 [No Abstract] [Full Text] [Related]